Regencell Bioscience Holdings LTD

Form 420-F13D

Insider Trading (Form 4)

NASDAQ
RGC
Regencell Bioscience Holdings LTD
Form 4: Regencell Director Sells Options Back to Company
Regencell Bioscience Holdings Ltd repurchased 70,600 stock options from Director and 10% Owner Dr. William Wing Yan Lo at $15.00 per option.
NASDAQ
RGC
Regencell Bioscience Holdings LTD
Form 4: Regencell Director Sells 19,000 Stock Options to Company
Regencell Bioscience Holdings Ltd Director Evana Yee Wah Hui sold 19,000 stock options back to the company at $15.00 per option.

Schedule 13D - Activist Investments

NASDAQ
RGC
Regencell Bioscience Holdings LTD
SCHEDULE: Regencell Bioscience Holdings Reports Significant Beneficial Ownership Post-Stock Split
Regencell (BVI) Limited and Yat-Gai Au have updated their beneficial ownership in Regencell Bioscience Holdings Ltd, reflecting an 86.2% and 88.6% stake respectively, following a 38-for-one forward stock split.
NASDAQ
RGC
Regencell Bioscience Holdings LTD
SCHEDULE 13D/A: Regencell CEO's Entity Consolidates Control with $6.2 Million Share Purchase, Boosting Stake to 86.2%
Regencell (BVI) Limited, an entity controlled by Regencell Bioscience Holdings Limited's CEO Yat-Gai Au, has acquired an additional 652,982 ordinary shares for $6.2 million, significantly increasing its beneficial ownership to 86.2% of the company.